BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15206013)

  • 41. Does intensive follow-up alter outcome in patients with advanced lung cancer?
    Benamore R; Shepherd FA; Leighl N; Pintilie M; Patel M; Feld R; Herman S
    J Thorac Oncol; 2007 Apr; 2(4):273-81. PubMed ID: 17409797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
    Lau D; Leigh B; Gandara D; Edelman M; Morgan R; Israel V; Lara P; Wilder R; Ryu J; Doroshow J
    J Clin Oncol; 2001 Jan; 19(2):442-7. PubMed ID: 11208837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
    Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
    J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
    Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
    Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer.
    Hollen PJ; Gralla RJ; Cox C; Eberly SW; Kris MG
    Lung Cancer; 1997 Oct; 18(2):119-36. PubMed ID: 9316004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW
    J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
    Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
    Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
    Gralla RJ; Edelman MJ; Detterbeck FC; Jahan TM; Loesch DM; Limentani SA; Govindan R; Peng G; Monberg MJ; Obasaju CK; Socinski MA
    Support Care Cancer; 2009 Mar; 17(3):307-13. PubMed ID: 18781341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicity and quality of life in published clinical trials for advanced lung cancer.
    Zwitter M
    Support Care Cancer; 2018 Oct; 26(10):3453-3459. PubMed ID: 29681014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.
    Ghimire S; Kyung E; Kim E
    Lung; 2013 Aug; 191(4):313-9. PubMed ID: 23715997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.
    Mannion E; Gilmartin JJ; Donnellan P; Keane M; Waldron D
    Support Care Cancer; 2014 May; 22(5):1417-28. PubMed ID: 24563068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends and predictors of Quality of Life in lung cancer survivors.
    Bade BC; Zhao J; Li F; Tanoue L; Lazowski H; Alfano CM; Silvestri GA; Irwin ML
    Lung Cancer; 2024 May; 191():107793. PubMed ID: 38640687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
    Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
    BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in endpoint selection and result interpretation in advanced non-small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study.
    Fernández-López C; Calleja-Hernández MÁ; Balbino JE; Cabeza-Barrera J; Expósito-Hernández J
    Thorac Cancer; 2019 Apr; 10(4):904-908. PubMed ID: 30868737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic variations and patient-reported quality of life among patients with lung cancer.
    Sloan JA; de Andrade M; Decker P; Wampfler J; Oswold C; Clark M; Yang P
    J Clin Oncol; 2012 May; 30(14):1699-704. PubMed ID: 22454423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
    Qi Y; Schild SE; Mandrekar SJ; Tan AD; Krook JE; Rowland KM; Garces YI; Soori GS; Adjei AA; Sloan JA
    J Thorac Oncol; 2009 Sep; 4(9):1075-82. PubMed ID: 19546817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS).
    Hollen PJ; Gralla RJ; Kris MG; Eberly SW; Cox C
    Support Care Cancer; 1999 May; 7(3):140-8. PubMed ID: 10335932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer.
    Cheng JH; Liu WS; Li ZM; Wang ZG
    Chin J Integr Med; 2007 Dec; 13(4):269-74. PubMed ID: 18180891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer.
    Koczywas M; Williams AC; Cristea M; Reckamp K; Grannis FW; Tiep BL; Uman G; Ferrell B
    Ann Surg Oncol; 2013 Jun; 20(6):1788-97. PubMed ID: 23143593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study.
    Liao YC; Shun SC; Liao WY; Yu CJ; Yang PC; Lai YH
    Oncol Nurs Forum; 2014 Mar; 41(2):E44-55. PubMed ID: 24578085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.